sFlt-1/PLGF 比值在子痫前期中的应用进展

doi:10.3969/j.issn.2095-5340.2025.02.013

发育医学电子杂志

2025, Vol. 13

Issue (2): 154-160 DOI: 10.3969/j.issn.2095-5340.2025.02.013

围产医学综述｜产科

sFlt-1/PLGF 比值在子痫前期中的应用进展

山蕾　周涛　邱娟娟　倪晴　柏婷　彭兰

（1. 温州医科大学附属衢州医院产科，浙江　衢州　324000 ；2. 南京医科大学附属苏州医院　产科，江苏　苏州 215000）

Application progress of sFlt-1/PLGF ratio in preeclampsia

Shan Lei, Zhou Tao, Qiu Juanjuan, et al

(1. Department of Obstetrics, Quzhou Hospital Affiliated to Wenzhou Medical University, Zhejiang, Quzhou 324000, China; 2. Department of Obstetrics, the Affiliated Suzhou Hospital of Nanjing Medical University, Jiangsu, Suzhou 215000, China)

摘要
相关文章
推荐阅读
Metrics

下载:

PDF (880KB)
输出: BibTeX | EndNote (RIS)

摘要 【摘要】 子痫前期是导致母婴不良结局甚至死亡的最常见原因之一。可溶性fms 样酪氨酸激酶-1（soluble
fms-like tyrosine kinase-1，sFlt-1）与胎盘生长因子（placental growth factor，PLGF）的比值直接反映了胎
盘合体滋养细胞的失衡状态，有望成为子痫前期预测、辅助诊断和预后的关键生物标志物。本文概述了
sFlt-1/PLGF 比值在子痫前期发病过程和疾病进展中的病理生理作用，并综述了sFlt-1/PLGF 比值在子
痫前期诊断、预测、治疗等方面的临床研究进展。

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词: 子痫前期妊娠期高血压疾病血管生成因子胎盘生长因子血管生成

Abstract: 【Abstract】Preeclampsia is one of the most common causes of adverse maternal and neonatal outcomes,even death. The ratio of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PLGF) as a direct indicator of the dysregulation within placental syncytiotrophoblast cells. This ratio is poised to emerge as a pivotal biomarker for the prediction, auxiliary diagnosis, and prognosis of preeclampsia. This article delineates the pathophysiological role of the sFlt-1/PLGF ratio in the etiology and progression of preeclampsia. Furthermore, it offers a comprehensive summary of the clinical research advancements concerning the application of the sFlt-1/PLGF ratio in diagnosing, predicting, and treatment of preeclampsia.

Key words: Preeclampsia Gestational hypertension Angiogenic factor Placental growth factor Angiogenesis

收稿日期: 2024-02-01 发布日期: 2025-03-31

基金资助: 南京医科大学姑苏学院专病队列项目（GSKY20220410）；苏州市医疗卫生科技创新（指令性）项目（SKY2022056）

通讯作者: 彭兰 E-mail: Nannanpeng123@hotmail.com

引用本文:

山蕾　周涛　邱娟娟　倪晴　柏婷　彭兰. sFlt-1/PLGF 比值在子痫前期中的应用进展[J]. 发育医学电子杂志, 2025, 13(2): 154-160.
Shan Lei, Zhou Tao, Qiu Juanjuan, et al. Application progress of sFlt-1/PLGF ratio in preeclampsia. Journal of Developmental Medicine(Electronic Version), 2025, 13(2): 154-160.

链接本文:

http://www.fyyxzz.com/CN/10.3969/j.issn.2095-5340.2025.02.013 或 http://www.fyyxzz.com/CN/Y2025/V13/I2/154

[1]	娄娟　顾成敏　李洋　鲁会红　冯敏. 基于血清sTNFR- Ⅱ与血栓弹力图评价子痫前期病情及母儿并发症发生风险[J]. 发育医学电子杂志, 2025, 13(2): 120-127.
[2]	朱文丽　娄艳慧　赵玉玲. 血清NLR、PLR 在子痫前期孕妇中的表达及其与血压、24 h 尿蛋白、围产结局的关系[J]. 发育医学电子杂志, 2025, 13(2): 128-132.
[3]	桂琦　侯伟　胡甲琳　姜淑芳　游艳琴　卢彦平. 系统性红斑狼疮与子痫前期因果关系的孟德尔随机化分析[J]. 发育医学电子杂志, 2024, 12(6): 415-421.
[4]	刘艳会　钟庆华　沈俊　梁琨. 早产儿脑损伤的危险因素分析[J]. 发育医学电子杂志, 2022, 10(2): 114-119.
[5]	郭玲玲　杨志清　王海星　张靓　郭燕青　郝崇奇　齐昊. 子痫前期对早产的影响及潜在交互作用[J]. 发育医学电子杂志, 2021, 9(6): 437-442.
[6]	韦秋圆　黄素静　王茹　马燕琳. 子痫前期患者胎盘微小RNA-30d 表达与内质网应激的相关性分析[J]. 发育医学电子杂志, 2021, 9(4): 287-291.
[7]	曾带娣　李仲均　萧丽娟　黄素然. 子痫前期患者胎盘中微小 RNA-34a 的表达及相关机制 [J]. 发育医学电子杂志, 2020, 8(4): 329-332.
[8]	陈文婷　李仲均　陈静华　曾带娣　黄素然　萧丽娟. 子痫前期孕妇胎盘组织中miR-205 表达的研究[J]. 发育医学电子杂志, 2019, 7(3): 214-217.
[9]	芦慧芬　刘艳蕾　邵璇　王雁玲. 妊娠过程中血液稳态变化的研究进展[J]. 发育医学电子杂志, 2015, 3(2): 68-73.

[1]	Neonatal Pediatrics Branch of Chinese Medical Doctor Association, Neonatal Health Professional Committee of China Maternal and Child 　　　　Health Association, Editorial Board of the Journal of Developmental 　Medicine (Electronic Version). Expert consensus on the use of placental transfusion in neonates with special obstetric conditions[J]. Journal of Developmental Medicine(Electronic Version), 2021, 9(5): 321 -328 .
[2]	XU Chen, WANG Liang, Li Wen, et al. Effect of Qi Lin Wan applied to patients with diminished ovarian reserve treated by in vitro fertilization and embryo transfer[J]. Journal of Developmental Medicine(Electronic Version), 2016, 4(3): 158 -162 .
[3]	Chen Huihui, Li Qiuping, Bian Jiaxin, et al. Research progress on factors related to the pathogenesis of bronchopulmonary dysplasia inpremature infants[J]. Journal of Developmental Medicine(Electronic Version), 2024, 12(4): 296 -301,308 .
[4]	Yeerfan•Aierken, Hanikezi•Keyoumu, Yeerdeng, et al. Molecular mechanism of hydronephrosis induced by ureteropelvic junction obstruction in children[J]. Journal of Developmental Medicine(Electronic Version), 2025, 13(1): 1 -10 .
[5]	Li Zhongyuan, Hu Xiaohong. Research advances in the relationship between tic disorder and gut microbiota in children[J]. Journal of Developmental Medicine(Electronic Version), 2025, 13(1): 73 -80 .
[6]	Wei Xian, Yang Shujie, Gan Bin, et al. Perinatal factors and complications analysis of premature infants with birth weight discordant twins at different gestational ages[J]. Journal of Developmental Medicine(Electronic Version), 2025, 13(1): 11 -18 .
[7]	Zhang Ying, Fu Yunrong, Li Yuxian, et al. Application effect of the early screening scale for autism spectrum disorder in pediatrichealth clinics[J]. Journal of Developmental Medicine(Electronic Version), 2025, 13(1): 19 -25 .
[8]	Yang Min, Liang Mengyao, Kang Jiajing, et al. Influencing factors and application value of anti-Müllerian hormone[J]. Journal of Developmental Medicine(Electronic Version), 2025, 13(1): 66 -72 .
[9]	Sun Xiaolei, Wang Guowei, Zhou Bin, et al. Effect of Mycoplasma pneumoniae on airway inflammation based on IL-4/IL-13 signaling pathway[J]. Journal of Developmental Medicine(Electronic Version), 2025, 13(1): 26 -32 .
[10]	Du Liyan, Meng Fanxue, Fan Songli, et al. Investigation of physical development and nutritional status of children aged 0-5 years and eating behavior analysis of overweight and obese children in Baoding city[J]. Journal of Developmental Medicine(Electronic Version), 2025, 13(1): 33 -39 .

Viewed

Full text

Abstract

Cited

Shared

Discussed